GLEOSTINE Trademark

Trademark Overview

On Tuesday, April 29, 2014, a trademark application was filed for GLEOSTINE with the United States Patent and Trademark Office. The USPTO has given the GLEOSTINE trademark a serial number of 86266575. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, August 18, 2025. This trademark is owned by NextSource Biotechnology, LLC. The GLEOSTINE trademark is filed in the Pharmaceutical Products category with the following description:

Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer
gleostine

General Information

Serial Number86266575
Word MarkGLEOSTINE
Filing DateTuesday, April 29, 2014
Status800 - REGISTERED AND RENEWED
Status DateMonday, August 18, 2025
Registration Number4733095
Registration DateTuesday, May 5, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 5, 2014

Trademark Statements

Goods and ServicesAnti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 14, 2014
Primary Code005
First Use Anywhere DateMonday, January 26, 2015
First Use In Commerce DateTuesday, January 27, 2015

Trademark Owner History

Party NameAZURITY PHARMACEUTICALS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressWOBURN, MA 01801
Party NameNextSource Biotechnology, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressPompano Beach, FL 33069
Party NameNextSource Biotechnology, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMiami, FL 33155
Party NameNextSource Biotechnology, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMiami, FL 33155

Trademark Events

Event DateEvent Description
Wednesday, May 14, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 2, 2014NEW APPLICATION ENTERED
Saturday, June 28, 2014ASSIGNED TO EXAMINER
Saturday, June 28, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 16, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 5, 2014PUBLISHED FOR OPPOSITION
Tuesday, August 5, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 30, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 5, 2015TEAS STATEMENT OF USE RECEIVED
Thursday, February 5, 2015USE AMENDMENT FILED
Thursday, March 12, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 19, 2015STATEMENT OF USE PROCESSING COMPLETE
Friday, March 27, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, March 28, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 5, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, May 5, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, May 13, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 13, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 13, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 13, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 13, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 14, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Thursday, May 14, 2020WITHDRAWAL OF ATTORNEY GRANTED
Monday, September 20, 2021TEAS SECTION 8 & 15 RECEIVED
Saturday, December 18, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, December 31, 2021POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Monday, January 3, 2022TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Wednesday, March 30, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, March 30, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, May 5, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Sunday, April 6, 2025TEAS SECTION 8 & 9 RECEIVED
Wednesday, May 28, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, June 5, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, June 5, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 5, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 5, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 18, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, August 18, 2025REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, August 18, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, August 18, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, June 5, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

gleostine cancer treatment preparations products prevention biological anti pharmaceutical